Overview

Study to Evaluate the Effects of Oral Administration of Lixivaptan in Patients With Congestive Heart Failure

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effects of oral lixivaptan capsules in patients with congestive heart failure.
Phase:
Phase 2
Details
Lead Sponsor:
CardioKine Inc.
Collaborator:
Cardiokine Biopharma, LLC